Study Details
Late phase II clinical study of FK949 (quetiapine fumarate) for psychiatric symptoms and behavioral disorders in patients with Alzheimer’s dementia-double-blind, placebo-controlled, parallel-group, dose-finding study
Clinicaltrials.gov ID
N/A
Astellas Study ID
FJ-949C-AH02
EudraCT ID
N/A
Condition
Dementia
Phase
Phase 2
Age
N/A - N/A
Sex
Female & Male
Product
quetiapine
Type
Interventional
Trial Dates
Oct 2003 - May 2005
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
214
Late phase II clinical study of FK949 (quetiapine fumarate) for psychiatric symptoms and behavioral disorders in patients with Alzheimer’s dementia-double-blind, placebo-controlled, parallel-group, dose-finding study
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Late phase II clinical study of FK949 (quetiapine fumarate) for psychiatric symptoms and behavioral disorders in patients with Alzheimer’s dementia-double-blind, placebo-controlled, parallel-group, dose-finding study? Contact us by filling our your information to the right and we’ll respond to you.